Dec 19 (Reuters) - Prometic Life Sciences Inc PLI.TO
* Prometic initiates rolling submission of its biologics license application ("BLA") for plasminogen with U.S. FDA
* On target for an expected commercial launch of plasminogen in USA in 2017 Source text for Eikon: Further company coverage: PLI.TO